批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2006/07/11 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/06/16 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2003/12/29 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2003/10/31 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/11/03 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/10/09 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/10/08 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/05/06 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/02/28 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/11/12 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/02/28 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品治疗等效的药品
活性成分:BETAMETHASONE VALERATE 剂型/给药途径:AEROSOL, FOAM;TOPICAL 规格:0.12% 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020934 |
001 |
NDA |
LUXIQ |
BETAMETHASONE VALERATE |
AEROSOL, FOAM;TOPICAL |
0.12% |
Discontinued |
Yes |
No |
AB |
1999/02/28
|
NORVIUM BIOSCIENCE |
078337 |
001 |
ANDA |
BETAMETHASONE VALERATE |
BETAMETHASONE VALERATE |
AEROSOL, FOAM;TOPICAL |
0.12% |
Prescription |
No |
No |
AB |
2012/11/26
|
PADAGIS ISRAEL |
208204 |
001 |
ANDA |
BETAMETHASONE VALERATE |
BETAMETHASONE VALERATE |
AEROSOL, FOAM;TOPICAL |
0.12% |
Prescription |
No |
Yes |
AB |
2017/05/24
|
TARO |
210639 |
001 |
ANDA |
BETAMETHASONE VALERATE |
BETAMETHASONE VALERATE |
AEROSOL, FOAM;TOPICAL |
0.12% |
Prescription |
No |
No |
AB |
2023/04/18
|
XIROMED |
215832 |
001 |
ANDA |
BETAMETHASONE VALERATE |
BETAMETHASONE VALERATE |
AEROSOL, FOAM;TOPICAL |
0.12% |
Prescription |
No |
No |
AB |
2024/08/22
|
ALEMBIC |